Amniotic fluid lamellar body count: Cost-effective screening for fetal lung maturity

Obstetrics and Gynecology

Volumn 94, Issue 3, 1999, Pages 481-482

  Mol, Ben W J ^a   Huisjes, Anjoke ^a   Franx, Arie ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

AMNION FLUID; CHEMISTRY; COST BENEFIT ANALYSIS; FETUS MATURITY; HUMAN; LUNG; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NOTE; PREDICTION AND FORECASTING; PRENATAL DEVELOPMENT;

AMNIOTIC FLUID; COST-BENEFIT ANALYSIS; FETAL ORGAN MATURITY; HUMANS; INFANT, NEWBORN; LUNG; PHOSPHATIDYLCHOLINES; PREDICTIVE VALUE OF TESTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SPHINGOMYELINS;

EID: 0033192465     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-199909000-00035     Document Type: Letter

References (3)

1. Harper MA, Lorentz WB. Immature lecithin/sphingomyelin ratios and neonatal respiratory course. Am J Obstet Gynecol 1993;168:495-8.
2. Lauria MR, Dombrowski MP, Delaney-Black V, Bottoms SF. Lung maturity test: Relation to source, clarity, gestation age, and neonatal outcome. J Reprod Med 1996;41:685-91.
3. Robertson PA, Sniderman SH, Laros RK, Cowan R, Heilbron D, Goldenberg RL, et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 to 1986. Am J Obstet Gynecol 1992;166:1629-45.